Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a federated analysis of 59 million patients’ primary care records in situ using OpenSAFELY

Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a federated analysis of 59 million patients’ primary care records in situ using OpenSAFELY

Background The COVID-19 pandemic affected how care was delivered to vulnerable patients, such as those with dementia or learning disability.Objective To explore whether this affected antipsychotic prescribing in at-risk populations.Methods With the approval of NHS England, we completed a retrospecti...

Full description

Bibliographic Details
Main Authors: Ben Goldacre, David Evans, Sam Harper, Orla Macdonald, Richard Croker, Jessica Morley, Andrew Brown, Brian MacKenna, William Hulme, Chris Bates, Amir Mehrkar, Peter Inglesby, Jonathan Cockburn, John Parry, Frank Hester, Amelia Green, Helen Curtis, Alex Walker, Ian Wood, Shaun O'Hanlon, Sebastian Bacon, Simon Davy, Caroline Morton, Tom Ward, Louis Fisher, Jon Massey, Iain Dillingham, Alex Eavis, Richard Jarvis, Dima Avramov, Nasreen Parkes, Ben Butler-Cole, Colm Andrews
Format: Article
Language:English
Published: BMJ Publishing Group 2023-10-01
Series:BMJ Mental Health
Online Access:https://ebmh.bmj.com/content/26/1/e300775.full

Internet

https://ebmh.bmj.com/content/26/1/e300775.full

Similar Items